| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.24 | 0.09 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.31 | 0.09 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.09 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |